Bio

Successful delivery in partnership with Syrma Johari validates manufacturing scale, strengthens commercial readiness, and supports planned U.S. market entry in 2026 ... .

Edit

YD Bio Limited Announces Strategic Partnership with YC Biotech Co., Ltd. to Establish a Taiwan-U.S. ...

Nasdaq Globe Newswire 25 Feb 2026

25, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio Ltd” or the “Company”) (Nasdaq ... today announced that its subsidiary YD Bio USA, Inc.

Edit

BIO-Europe Spring® 2026 Charts the Future of Life Sciences from Lisbon’s Shores

Nasdaq Globe Newswire 25 Feb 2026

25, 2026 (GLOBE NEWSWIRE) -- The 20th annual BIO-Europe Spring is heading to Lisbon, Portugal, from March 23–25, ...

Edit

Statement of Changes in Beneficial Ownership (Form 4) (Zura Bio Ltd)

Public Technologies 25 Feb 2026

) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b) ... See Instruction 10 ... Washington, D.C ... 0.5 ... 2 ... Zura Bio Ltd [ZURA] 5 ... C/O ZURA BIO LIMITED, 1489 W ... 6 ... C/O ZURA BIO LIMITED ... Zura Bio Ltd.

Edit

Intelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and Driving Gross Margin Expansion in Anticipation of Planned U.S. Entry (Form 8-K) (Intelligent Bio Solutions Inc)

Public Technologies 25 Feb 2026

Intelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and Driving Gross Margin Expansion in Anticipation of Planned U.S ... NEW YORK, February 25, 2026 - Intelligent Bio Solutions Inc.

Edit

Zura Bio Announces Pricing of $125 Million Public Offering of Class A Ordinary Shares and Pre-Funded Warrants

Pharmiweb 25 Feb 2026

HENDERSON, Nev.--(BUSINESS WIRE)--$ZURA #TeamZura--Zura Bio Limited (Nasdaq ... All of the Class A ordinary shares and pre-funded warrants are to be sold by Zura ... Wedbush PacGrow is acting as lead manager for the proposed offering ... ABOUT ZURA ... Contacts ... .

Edit

Statement of Changes in Beneficial Ownership (Form 4) (TELA Bio Inc)

Public Technologies 25 Feb 2026

) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b) ... See Instruction 10 ... 0.5 ... 2 ... TELA Bio, Inc ... C/O TELA BIO, INC., 1 GREAT VALLEY PARKWAY, SUITE 24 3 ... 6 ... C/O TELA BIO, INC ... TELA Bio Inc.

Edit

Initial Statement of Beneficial Ownership (Form 3) (Zura Bio Ltd)

Public Technologies 25 Feb 2026

) FORM 3. UNITED STATES SECURITIES AND EXCHANGE COMMISSION. Washington, D.C ... OMB Number. 3235-0104. Estimated average burden hours per response... 0.5 ... Eisner Mark. 2 ... Zura Bio Ltd [ZURA] ... C/O ZURA BIO LIMITED, 1489 W ... #110 4 ... C/O ZURA BIO LIMITED ... Zura Bio Ltd.

Edit

Panome Bio Introduces MassID™, a Major Advance in Untargeted Metabolomics Data Analysis for Biomarker Discovery and Drug Development

PR Newswire 25 Feb 2026

Patti, PhD, Chief Scientific Officer of Panome Bio and Professor at Washington University in St ... MassID is now integrated into Panome Bio's metabolomics service offerings and is available immediately to biopharma, biotech, and academic partners.

Edit

Zura Bio Announces Proposed Public Offering of Class A Ordinary Shares and Pre-Funded Warrants

Pharmiweb 25 Feb 2026

HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq ... All of the Class A ordinary shares and pre-funded warrants to be sold in the proposed offering will be sold by Zura ... Wedbush PacGrow is acting as lead manager for the proposed offering ... .

Edit

New Study Finds E15 Saved Minnesota Drivers $24.7 million In 2024, Delivering Consistent Savings At The Pump (Minnesota Bio-Fuels Association)

Public Technologies 25 Feb 2026

... option often marketed as Unleaded 88 that has consistently been priced below traditional gasoline blends, according to a new study released today by the Minnesota Bio-Fuels Association (MN Bio-Fuels).

Podcasts:

Alternative Video Results

Latest News for: bio

Backlash over tainted officer getting charge of Haffkine Bio Pharma

Cellipont Bioservices and Soter Bio Announce Strategic Collaboration to Support Integrated U.S. Cell Therapy Manufacturing

Zura Bio Announces Pricing of $125 Million Public Offering of Class A Ordinary Shares and ...

Upstream Bio to Participate in Upcoming March Investor Conferences

Intelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and ...

YD Bio Limited Announces Strategic Partnership with YC Biotech Co., Ltd. to Establish a Taiwan-U.S. ...

BIO-Europe Spring® 2026 Charts the Future of Life Sciences from Lisbon’s Shores

Statement of Changes in Beneficial Ownership (Form 4) (Zura Bio Ltd)

Intelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and Driving Gross Margin Expansion in Anticipation of Planned U.S. Entry (Form 8-K) (Intelligent Bio Solutions Inc)

Zura Bio Announces Pricing of $125 Million Public Offering of Class A Ordinary Shares and Pre-Funded Warrants

Statement of Changes in Beneficial Ownership (Form 4) (TELA Bio Inc)

Initial Statement of Beneficial Ownership (Form 3) (Zura Bio Ltd)

Panome Bio Introduces MassID™, a Major Advance in Untargeted Metabolomics Data Analysis for Biomarker Discovery and Drug Development

Zura Bio Announces Proposed Public Offering of Class A Ordinary Shares and Pre-Funded Warrants

New Study Finds E15 Saved Minnesota Drivers $24.7 million In 2024, Delivering Consistent Savings At The Pump (Minnesota Bio-Fuels Association)

Article Search

EXPLORE WN.com